186 related articles for article (PubMed ID: 38685122)
1. Dietary inflammatory impact on NAFLD development in obese vs. lean individuals: an analysis based on NHANES 2003-2018.
Li L; Shu X; Yi Y; Wang C; Li J; Ding Y; Li J; Chang Y
Lipids Health Dis; 2024 Apr; 23(1):127. PubMed ID: 38685122
[TBL] [Abstract][Full Text] [Related]
2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
3. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
4. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
[TBL] [Abstract][Full Text] [Related]
5. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
6. Role of BMI in the relationship between dietary inflammatory index and non-alcoholic fatty liver disease: an intermediary analysis.
Fan L; Zhao S; Shi H; Zhang S
Scand J Gastroenterol; 2023; 58(10):1159-1165. PubMed ID: 37211749
[TBL] [Abstract][Full Text] [Related]
7. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Younes R; Govaere O; Petta S; Miele L; Tiniakos D; Burt A; David E; Vecchio FM; Maggioni M; Cabibi D; McLeod D; Pareja MJ; Fracanzani AL; Aller R; Rosso C; Ampuero J; Gallego-Durán R; Armandi A; Caviglia GP; Zaki MYW; Liguori A; Francione P; Pennisi G; Grieco A; Birolo G; Fariselli P; Eslam M; Valenti L; George J; Romero-Gómez M; Anstee QM; Bugianesi E
Gut; 2022 Feb; 71(2):382-390. PubMed ID: 33541866
[TBL] [Abstract][Full Text] [Related]
8. The association between dietary inflammatory index (DII) scores and c-reactive protein (CRP) and nonalcoholic fatty liver disease (NAFLD) in a general population cohort.
Doustmohammadian A; Amirkalali B; Esfandyari S; Motamed N; Maadi M; Shivappa N; Gholizadeh E; Hébert JR; Zamani F
Clin Nutr ESPEN; 2024 Apr; 60():156-164. PubMed ID: 38479904
[TBL] [Abstract][Full Text] [Related]
9. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
Li MR; Li JZ; Li JY; Wang CC; Yuan RK; Ye LH; Liu YY; Liang XJ; Zhang HC; Liu ZQ; Zeng DY; Zhang XD; Wang DH; Li JQ; Li TY; Yang L; Cao Y; Pan Y; Lin XG; Pan CQ; Dai EH; Dong ZY
Obes Facts; 2023; 16(5):427-434. PubMed ID: 37231905
[TBL] [Abstract][Full Text] [Related]
12. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
15. Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis.
Wu W; Zhang Z; Qi Y; Zhang H; Zhao Y; Li J
Ann Med; 2023 Dec; 55(1):2195203. PubMed ID: 37036742
[TBL] [Abstract][Full Text] [Related]
16. Association of Dietary Inflammatory Index with anthropometric indices in children and adolescents: the weight disorder survey of the Childhood and Adolescence Surveillance and Prevention of Adult Non-communicable Disease (CASPIAN)-IV study.
Aslani Z; Qorbani M; Hébert JR; Shivappa N; Motlagh ME; Asayesh H; Mahdavi-Gorabi A; Kelishadi R
Br J Nutr; 2019 Feb; 121(3):340-350. PubMed ID: 30507370
[TBL] [Abstract][Full Text] [Related]
17. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
[TBL] [Abstract][Full Text] [Related]
18. Validation and Comparison of Two Dietary Indexes for Predicting Nonalcoholic Fatty Liver Disease in US Adults.
Li R; Chen Z
J Nutr; 2023 Jan; 152(12):2865-2876. PubMed ID: 36190320
[TBL] [Abstract][Full Text] [Related]
19. Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults.
Zhang Z; Wang L; Lin Z; Yan W; Chen J; Zhang X; Ye W; Li J; Li Z
Front Nutr; 2023; 10():1102660. PubMed ID: 36761224
[TBL] [Abstract][Full Text] [Related]
20. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
Long MT; Noureddin M; Lim JK
Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
